North America Active Pharmaceutical Ingredients Market: By Drug Type: Innovative Active Pharmaceutical Ingredients (API), Generic Active Pharmaceutical Ingredients (API); By Type of Manufacturer: Captive Manufacturers, Merchant API Manufacturers; By Type of Synthesis; By Application; Regional Analysis; Supplier Landscape; 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Active Pharmaceutical Ingredients Market Overview 
    3.1    Global Active Pharmaceutical Ingredients Market
        3.1.1    Global Active Pharmaceutical Ingredients Market Historical Value (2017-2023) 
        3.1.2    Global Active Pharmaceutical Ingredients Market Forecast Value (2024-2032)
    3.2    North America Active Pharmaceutical Ingredients Market
        3.2.1    North America Active Pharmaceutical Ingredients Market Historical Value (2017-2023) 
        3.2.2    North America Active Pharmaceutical Ingredients Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    North America Active Pharmaceutical Ingredients Market Landscape*
    5.1        North America Active Pharmaceutical Ingredients Market: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2        North America Active Pharmaceutical Ingredients Market: Product Landscape
        5.2.1    Analysis by Drug Type    
        5.2.2    Analysis by Type of Synthesis
        5.2.3    Analysis by Type of Application
6    North America Active Pharmaceutical Ingredients Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis
        6.3.1    Political
        6.3.2    Economic
        6.3.3    Social
        6.3.4    Technological
        6.3.5    Legal
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    North America Active Pharmaceutical Ingredients Market Segmentation (2017-2032)
        7.1    North America Active Pharmaceutical Ingredients Market (2017-2032) by Drug Type
            7.1.1    Market Overview
            7.1.2    Innovative Active Pharmaceutical Ingredients (API)
            7.1.3    Generic Active Pharmaceutical Ingredients (API)
        7.2    North America Active Pharmaceutical Ingredients Market (2017-2032) by Type of Manufacturer
            7.2.1    Market Overview
            7.2.2    Captive Manufacturers
            7.2.3    Merchant API Manufacturers
        7.3    North America Active Pharmaceutical Ingredients Market (2017-2032) by Type of Synthesis
            7.3.1    Market Overview
            7.3.2    Synthetic Active Pharmaceutical Ingredients (API)
            7.3.3    Biotech Active Pharmaceutical Ingredients (API)
        7.4    North America Active Pharmaceutical Ingredients Market (2017-2032) by Application
            7.4.1    Market Overview
            7.4.2    Communicable Disease
            7.4.3    CNS & Neurology
            7.4.4    Oncology
            7.4.5    Endocrinology
            7.4.6    Gastroenterology
            7.4.7    Other Therapeutic Application
        7.5    North America Active Pharmaceutical Ingredients Market (2017-2032) by Country
            7.5.1    Market Overview
            7.5.2    United States
            7.5.3    Canada
8    United States Active Pharmaceutical Ingredients Market (2017-2032)
    8.1    United States Active Pharmaceutical Ingredients Market (2017-2032) by Drug Type
        8.1.1    Market Overview    
        8.1.2    Innovative Active Pharmaceutical Ingredients (API)
        8.1.3    Generic Active Pharmaceutical Ingredients (API)
    8.2    United States Active Pharmaceutical Ingredients Market (2017-2032) by Type of Manufacturer
        8.2.1    Market Overview
        8.2.2    Captive Manufacturers
        8.2.3    Merchant API Manufacturers 
    8.3    United States Active Pharmaceutical Ingredients Market (2017-2032) by Type of Synthesis
        8.3.1    Market Overview
        8.3.2    Synthetic Active Pharmaceutical Ingredients (API)
        8.3.3    Biotech Active Pharmaceutical Ingredients (API) 
    8.4    United States Active Pharmaceutical Ingredients Market (2017-2032) by Application
        8.4.1    Market Overview
        8.4.2    Communicable Disease
        8.4.3    CNS & Neurology
        8.4.4    Oncology
        8.4.5    Endocrinology
        8.4.6    Gastroenterology
        8.4.7    Other Therapeutic Application
9    Canada Active Pharmaceutical Ingredients Market (2017-2032)
    9.1    Canada Active Pharmaceutical Ingredients Market (2017-2032) by Drug Type
        9.1.1    Market Overview    
        9.1.2    Innovative Active Pharmaceutical Ingredients (API)
        9.1.3    Generic Active Pharmaceutical Ingredients (API)
    9.2    Canada Active Pharmaceutical Ingredients Market (2017-2032) by Type of Manufacturer
        9.2.1    Market Overview
        9.2.2    Captive Manufacturers
        9.2.3    Merchant API Manufacturers
    9.3    Canada Active Pharmaceutical Ingredients Market (2017-2032) by Type of Synthesis
        9.3.1    Market Overview
        9.3.2    Synthetic Active Pharmaceutical Ingredients (API)
        9.3.3    Biotech Active Pharmaceutical Ingredients (API)
    9.4    Canada Active Pharmaceutical Ingredients Market (2017-2032) by Application
        9.4.1    Market Overview
        9.4.2    Communicable Disease
        9.4.3    CNS & Neurology
        9.4.4    Oncology
        9.4.5    Endocrinology
        9.4.6    Gastroenterology
        9.4.7    Other Therapeutic Application
10    Regulatory Framework
11    Patent Analysis
    11.1    Analysis by Type of Patent
    11.2    Analysis by Publication Year
    11.3    Analysis by Issuing Authority
    11.4    Analysis by Patent Age
    11.5    Analysis by CPC Analysis
    11.6    Analysis by Patent Valuation 
    11.7    Analysis by Key Players
12    Funding and Investment Analysis
    12.1     Analysis by Funding Instances
    12.2     Analysis by Type of Funding
    12.3     Analysis by Funding Amount
    12.4     Analysis by Leading Players
    12.5     Analysis by Leading Investors
    12.6     Analysis by Geography
13    Strategic Initiatives
    13.1     Analysis by Partnership Instances
    13.2     Analysis by Type of Partnership
    13.3     Analysis by Leading Players
    13.4     Analysis by Geography
14    Supplier Landscape
    14.1     Market Share by Top 5 Companies
    14.2     AbbVie Inc.
        14.2.1    Financial Analysis
        14.2.2    Product Portfolio
        14.2.3    Demographic Reach and Achievements
        14.2.4    Company News and Development
        14.2.5    Certifications 
    14.3    Bristol-Myers Squibb Company
        14.3.1    Financial Analysis
        14.3.2    Product Portfolio
        14.3.3    Demographic Reach and Achievements
        14.3.4    Company News and Development
        14.3.5    Certifications
    14.4    Merck & Co., Inc. 
        14.4.1    Financial Analysis
        14.4.2    Product Portfolio
        14.4.3    Demographic Reach and Achievements
        14.4.4    Company News and Development
        14.4.5    Certifications
    14.5    Eli Lilly and Company
        14.5.1    Financial Analysis
        14.5.2    Product Portfolio
        14.5.3    Demographic Reach and Achievements
        14.5.4    Company News and Development
        14.5.5    Certifications
    14.6    Sandoz 
        14.6.1    Financial Analysis
        14.6.2    Product Portfolio
        14.6.3    Demographic Reach and Achievements
        14.6.4    Company News and Development
        14.6.5    Certifications
    14.7    Biospectra
        14.7.1    Financial Analysis
        14.7.2    Product Portfolio
        14.7.3    Demographic Reach and Achievements
        14.7.4    Company News and Development
        14.7.5    Certifications
    14.8    Sun Pharmaceuticals Industries Ltd.
        14.8.1    Financial Analysis
        14.8.2    Product Portfolio
        14.8.3    Demographic Reach and Achievements
        14.8.4    Company News and Development
        14.8.5    Certifications
    14.9    Mylan
        14.9.1    Financial Analysis
        14.9.2    Product Portfolio
        14.9.3    Demographic Reach and Achievements
        14.9.4    Company News and Development
        14.9.5    Certifications
    14.10    Dr. Reddy’s Laboratories
        14.10.1    Financial Analysis
        14.10.2    Product Portfolio
        14.10.3    Demographic
        14.10.4    Company News and Development
        14.10.5    Certifications
    14.11    Aurobindo Pharma 
        14.11.1    Financial Analysis
        14.11.2    Product Portfolio
        14.11.3    Demographic Reach and Achievements
        14.11.4    Company News and Development
        14.11.5    Certifications
15    North America Active Pharmaceutical Ingredients Market – Distribution Model (Additional Insight)
    15.1     Overview 
    15.2     Potential Distributors 
    15.3     Key Parameters for Distribution Partner Assessment 
16    Key Opinion Leaders (KOL) Insights (Additional Insight)

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.